Journal ArticleDOI
Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique?
O. Wegelin,Harm H.E. van Melick,Lotty Hooft,J.L.H. Ruud Bosch,Hans B. Reitsma,Jelle O. Barentsz,Diederik M. Somford +6 more
TLDR
It is shown that magnetic resonance imaging-guided biopsy detects more clinically significant prostate cancer (PCa) and less insignificant PCa compared with systematic biopsy in men at risk for PCa.About:
This article is published in European Urology.The article was published on 2017-04-01. It has received 334 citations till now.read more
Citations
More filters
Journal ArticleDOI
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
Veeru Kasivisvanathan,Antti Rannikko,Marcelo Borghi,Valeria Panebianco,Lance A. Mynderse,Markku H. Vaarala,Alberto Briganti,Lars Budäus,Giles Hellawell,Richard G. Hindley,Monique J. Roobol,Scott E. Eggener,Maneesh Ghei,Arnauld Villers,Franck Bladou,Geert M. Villeirs,Jaspal Virdi,S. Boxler,Grégoire Robert,Paras B. Singh,Wulphert Venderink,Boris Hadaschik,Alain Ruffion,Jim C. Hu,Daniel Margolis,Sebastien Crouzet,Laurence Klotz,Samir S. Taneja,Peter A. Pinto,Inderbir S. Gill,Clare Allen,Francesco Giganti,Alex Freeman,Stephen Morris,Shonit Punwani,Norman R. Williams,Chris Brew-Graves,Jonathan J Deeks,Yemisi Takwoingi,Mark Emberton,Caroline M. Moore +40 more
TL;DR: The use of risk assessment with MRI before biopsy and MRI‐targeted biopsy was superior to standard transrectal ultrasonography–guided biopsy in men at clinical risk for prostate cancer who had not undergone biopsy previously.
Journal ArticleDOI
Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study.
Olivier Rouvière,Philippe Puech,Raphaële Renard-Penna,Michel Claudon,Catherine Roy,Florence Mège-Lechevallier,Myriam Decaussin-Petrucci,Marine Dubreuil-Chambardel,Laurent Magaud,Laurent Remontet,Laurent Remontet,Alain Ruffion,Marc Colombel,Sebastien Crouzet,Anne-Marie Schott,Laurent Lemaitre,Muriel Rabilloud,Muriel Rabilloud,Nicolas Grenier,Nicolas Barry Delongchamps,Romain Boutier,Flavie Bratan,S. Brunelle,Philippe Camparo,Pierre Colin,Jean-Michel Correas,François Cornelis,François Cornud,Fanny Cros,Jean-Luc Descotes,Pascal Eschwege,Gaelle Fiard,Jean-Philippe Fendler,Hocine Habchi,Philippe Hallouin,Ahmed Khairoune,Hervé Lang,Y. Lebras,F Lefèvre,Bernard Malavaud,Paul C. Moldovan,Nicolas Mottet,Pierre Mozer,Pierre Nevoux,G. Pagnoux,Gilles Pasticier,Daniel Portalez,E. Potiron,Athivada Soto Thammavong,Marc-Olivier Timsit,Arnault Viller,Jochen Walz +51 more
TL;DR: Obtaining a multiparametric MRI before biopsy in biopsy-naive patients can improve the detection of clinically significant prostate cancer but does not seem to avoid the need for systematic biopsy.
Journal ArticleDOI
Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study.
Marloes van der Leest,Erik B. Cornel,Bas Israël,Rianne J. Hendriks,Anwar R. Padhani,Martijn Hoogenboom,Patrik Zamecnik,Dirk Bakker,Anglita Yanti Setiasti,Jeroen Veltman,Huib van den Hout,Hans van der Lelij,Inge M. van Oort,Sjoerd O. Klaver,Frans M.J. Debruyne,Michiel Sedelaar,Gerjon Hannink,Maroeska M. Rovers,Christina A. Hulsbergen-van de Kaa,Jelle O. Barentsz +19 more
TL;DR: In biopsy-naïve men, the MRI pathway compared with the TRUSGB pathway results in an identical detection rate of csPCa, with significantly fewer insignPCa cases, in this high-quality standard study.
Journal ArticleDOI
Prostate MRI, with or without MRI‐targeted biopsy, and systematic biopsy for detecting prostate cancer
Frankâ€Jan H Drost,Daniël F Osses,Daan Nieboer,Ewout W. Steyerberg,Chris H. Bangma,Monique J. Roobol,Ivo G. Schoots +6 more
TL;DR: The diagnostic accuracy of the index tests MRI only, MRI-targeted biopsy, the MRI pathway and systematic biopsy as compared to template-guidedBiopsy as the reference standard in detecting clinically significant prostate cancer as the target condition was determined.
Journal ArticleDOI
What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel
Paul C. Moldovan,Thomas Van den Broeck,Richard Sylvester,Lorenzo Marconi,Joaquim Bellmunt,Roderick C.N. van den Bergh,Michel Bolla,Erik Briers,Marcus G. Cumberbatch,Nicola Fossati,Tobias Gross,Ann Henry,Steven Joniau,Theo H. van der Kwast,Vsevolod Matveev,Henk G. van der Poel,Maria De Santis,Ivo G. Schoots,Thomas Wiegel,Cathy Yuhong Yuan,Philip Cornford,Nicolas Mottet,Thomas B. Lam,Thomas B. Lam,Olivier Rouvière +24 more
TL;DR: The results suggest that multiparametric magnetic resonance imaging (MRI) scan can be used to reliably predict the absence of prostate cancer in patients suspected of having prostate cancer, thereby avoiding a prostate biopsy, but its accuracy is variable and influenced by the prostate cancer risk.
References
More filters
Journal ArticleDOI
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
TL;DR: Moher et al. as mentioned in this paper introduce PRISMA, an update of the QUOROM guidelines for reporting systematic reviews and meta-analyses, which is used in this paper.
Journal ArticleDOI
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
TL;DR: A structured summary is provided including, as applicable, background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions and implications of key findings.
Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration
Journal ArticleDOI
QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
Penny Whiting,Anne W S Rutjes,Marie Westwood,Susan Mallett,Jonathan J Deeks,Johannes B. Reitsma,Mariska M.G. Leeflang,Jonathan A C Sterne,Patrick M.M. Bossuyt +8 more
TL;DR: The QUADAS-2 tool will allow for more transparent rating of bias and applicability of primary diagnostic accuracy studies.
Related Papers (5)
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
Veeru Kasivisvanathan,Antti Rannikko,Marcelo Borghi,Valeria Panebianco,Lance A. Mynderse,Markku H. Vaarala,Alberto Briganti,Lars Budäus,Giles Hellawell,Richard G. Hindley,Monique J. Roobol,Scott E. Eggener,Maneesh Ghei,Arnauld Villers,Franck Bladou,Geert M. Villeirs,Jaspal Virdi,S. Boxler,Grégoire Robert,Paras B. Singh,Wulphert Venderink,Boris Hadaschik,Alain Ruffion,Jim C. Hu,Daniel Margolis,Sebastien Crouzet,Laurence Klotz,Samir S. Taneja,Peter A. Pinto,Inderbir S. Gill,Clare Allen,Francesco Giganti,Alex Freeman,Stephen Morris,Shonit Punwani,Norman R. Williams,Chris Brew-Graves,Jonathan J Deeks,Yemisi Takwoingi,Mark Emberton,Caroline M. Moore +40 more